Join us at IO360

Step into the World of AI-Driven Spatial Biomarkers.

Your next-gen cancer treatments need better companions. Advance your ADC, bispecific, and immunotherapy programs with a next-gen diagnostic strategy.

Attend Our Talk

How AI-powered Diagnostic Assays Can Advance Patient Enrollment in Clinical Trials

Tuesday, Feb 27 at 4:25 PM

Tissue pathology has been the gateway to trial enrollment and treatment decisions for several decades. The advent of AI-based tissue analysis platforms helps maximize the biomarker insights and decisions from each patient sample. This talk will provide the status of digital pathology diagnostic assays for clinical development in oncology and how AI-powered tissue biomarkers can make trials more efficient.


Oscar Puig, PhD

VP Translational Medicine & Diagnostics

Book a Meeting with Us

Oscar Puig, PhD

VP Translational Medicine & Diagnostics

Jonathan Daniels

SVP Strategy & BD

Matthew Alessandri

VP of Pharma BD

Please complete the form below to schedule a meeting with our team at IO360:

Add Your Heading Text Here